Biogen | BIIB - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
AbbVie USD 435.86B 8.73B 2026-08
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
ALKERMES USD 7.93B 806M 2026-08
Amgen USD 209.65B 14.21B 2026-08
Bayer EUR 48.39B 834.21M 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
Incyte USD 26.84B 4.19B 2026-08
Merck USD 324.18B 6.81B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 153.17B 14.73B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Sarepta Therapeutics USD 1.5B 402M 2026-08
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
United Therapeutics USD 24.42B 1.42B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08